Self-assembled nanoparticles of hyaluronic acid/poly(dl-lactide-co-glycolide) block copolymer

Colloids and Surfaces B: Biointerfaces

Volumn 90, Issue 1, 2012, Pages 28-35

  Jeong, Young Il ^a   Kim, Do Hyung ^a   Chung, Chung Wook ^a   Yoo, Jin Ju ^a   Choi, Kyung Ha ^a   Kim, Cy Hyun ^a   Ha, Seung Hee ^a   Kang, Dae Hwan ^a  

^a Pusan National University Yangsan Hospital   (South Korea)

Author keywords

Block copolymer; CD44; Hyaluronic acid; Nanoparticles; PLGA; Receptor mediated endocytosis

Indexed keywords

ANTI-TUMOR ACTIVITIES; ANTI-TUMORS; CD44; DOXORUBICIN; FLUORESCENCE INTENSITIES; HUMAN COLON; HYALURONIC ACID; HYALURONIC ACIDS; NMR STUDIES; PLGA; POLY(DL-LACTIDE-COGLYCOLIDE); RECEPTOR-MEDIATED ENDOCYTOSIS; RED FLUORESCENCE; SELF ASSEMBLED NANOPARTICLES; TUMOR CELLS;

BLOCK COPOLYMERS; CELLS; FLOW CYTOMETRY; FLUORESCENCE; MOLECULAR BIOLOGY; ORGANIC ACIDS; TUMORS;

NANOPARTICLES;

DOXORUBICIN; HERMES ANTIGEN; HYALURONIC ACID; NANOPARTICLE; POLYGLACTIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CARCINOMA; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG RELEASE; DRUG TARGETING; ENDOCYTOSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

ANTIGENS, CD44; ANTINEOPLASTIC AGENTS; BINDING, COMPETITIVE; CARCINOMA; CELL LINE, TUMOR; COLONIC NEOPLASMS; DELAYED-ACTION PREPARATIONS; DEUTERIUM OXIDE; DOXORUBICIN; DRUG CARRIERS; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENCE; HUMANS; HYALURONIC ACID; HYDROPHOBIC AND HYDROPHILIC INTERACTIONS; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MOLECULAR TARGETED THERAPY; POLYGLYCOLIC ACID;

EID: 82355181040     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2011.09.043     Document Type: Article

References (35)

1. Bulpitt P., Aeschlimann D. J. Biomed. Mater. Res. 1999, 47:152-169.
2. Laurent T.C., Laurent U.B.G., Fraser J.R.E. Ann. Rheum. Dis. 1995, 54:429-432.
3. Culty M., Nguyen H.A., Underhill C.B. J. Cell Biol. 1992, 116:1055-1062.
4. Hall C.L., Yang B.H., Yang X.W., Zhang S.W., Turley M., Samuel S., Lange L.A., Wang C., Curpen G.D., Savani R.C., Greenberg A.H., Turley E.A. Cell 1995, 82:19-28.
5. Knudsen W. Am. J. Pathol. 1996, 148:1721-1726.
6. Yeo T.K., Nagy J.A., Yeo K.T., Dvorak H.F., Toole B.P. Am. J. Pathol. 1996, 148:1733-1740.
7. Akiyama Y., Jung S., Salhia B., Lee S., Hubbard S., Taylor M., Mainprize T., Akaishi K., Furth W., Rutka J.T. J. Neurooncol. 2001, 53:115-127.
8. Junker N., Latini S., Petersen L.N., Kristjansen P.E. Oncol. Rep. 2003, 10:609-616.
9. Ladeda V., Aguirre Ghiso J.A., Bal de Kier Joffe E. Exp. Cell Res. 1998, 242:515-527.
10. Turley E.A., Belch A.J., Poppema S., Pilarski L.M. Blood 1993, 81:446-453.
11. Jeong Y.I., Kim S.T., Jin S.G., Ryu H.H., Jin Y.H., Jung T.Y., Kim I.Y., Jung S. J. Pharm. Sci. 2008, 97:1268-1276.
12. Luo Y., Prestwich G.D. Bioconjug. Chem. 1999, 10:755-763.
13. Orian-Rousseau V. Eur. J. Cancer 2010, 46:1271-1277.
14. Ossipov D.A. Expert Opin. Drug Deliv. 2010, 7:681-703.
15. Freed L.E., Vunjak-Novakovic G., Biron R.J., Eagles D.B., Lesnoy D.C., Barlow S.K., Langer R. Biotechnology 1994, 12:689-693.
16. Moriyama K., Ooya T., Yui N. J. Control. Release 1999, 59:77-86.
17. Vercruysse K.P., Prestwich G.D. Crit. Ther. Rev. Drug Carrier Syst. 1998, 15:513-555.
18. Akiyoshi K., Kobayashi S., Shichibe S., Mix D., Baudys M., Kim S.W., Sunamoto J. J. Control. Release 1998, 54:313-320.
19. Gref R., Minamitake Y., Peracchia M.T., Trubetskoy V., Torchilin V., Langer R. Science 1994, 263:1600-1603.
20. Jeong Y.I., Choi K.C., Song C.E. Arch. Pharm. Res. 2006, 29:712-719.
21. Jeong Y.I., Seom S.J., Park I.K., Lee H.C., Kang I.C., Akaike T., Cho C.S. Int. J. Pharm. 2005, 296:151-161.
22. Kwon G.S., Naito M., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Pharm. Res. 1995, 12:192-195.
23. La S.B., Okano T., Kataoka K. J. Pharm. Sci. 1996, 85:85-90.
24. Suo A., Qian J., Yao Y., Zhang W. Int. J. Nanomedicine. 2010, 5:1029-1038.
25. Kwon G.S., Yokoyama M., Okano T., Sakurai Y., Kataoka K. Pharm. Res. 1993, 10:970-974.
26. Sun H., Guo B., Li X., Cheng R., Meng F., Liu H., Zhong Z. Biomacromolecules 2010, 11:848-854.
27. Maruyama A., Watanabe H., Ferdous A., Katoh M., Ishihara T., Akaike T. Bioconjug. Chem. 1998, 9:292-299.
28. Luo Y., Ziebell M.R., Prestwich G.D. Biomacromolecules 2000, 1:208-218.
29. Auzenne E., Ghosh S.C., Khodadadian M., Rivera B., Farquhar D., Price R.E., Ravoori M., Kundra V., Freedman R.S., Klostergaard J. Neoplasia 2007, 9:479-486.
30. Yin D.S., Ge Z.Q., Yang W.Y., Liu C.X., Yuan Y.J. Cancer Lett. 2006, 243:71-79.
31. Hyung W., Ko H., Park J., Lim E., Park S.B., Park Y.J., Yoon H.G., Suh J.S., Haam S., Huh Y.M. Biotechnol. Bioeng. 2008, 99:442-454.
32. Rivkin I., Cohen K., Koffler J., Melikhov D., Peer D., Margalit R. Biomaterials 2010, 31:7106-7114.
33. Gaumet M., Vargas A., Gurny R., Delie F. Eur. J. Pharm. Biopharm. 2008, 69:1-9.
34. Luo Y., Bernshaw N.J., Lu Z.R., Kopecek J., Prestwich G.D. Pharm. Res. 2002, 19:396-402.
35. Jeong Y.I., Kim D.H., Chung C.W., Yoo J.J., Choi K.H., Kim C.H., Ha S.H., Kang D.H. Int. J. Nanomed. 2011, 6:1415-1427.